| 000 | 01884 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250516114816.0 | ||
| 264 | 0 | _c20130814 | |
| 008 | 201308s 0 0 eng d | ||
| 022 | _a1476-5381 | ||
| 024 | 7 |
_a10.1111/bph.12002 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aJehle, J | |
| 245 | 0 | 0 |
_aMechanisms of zolpidem-induced long QT syndrome: acute inhibition of recombinant hERG K(+) channels and action potential prolongation in human cardiomyocytes derived from induced pluripotent stem cells. _h[electronic resource] |
| 260 |
_bBritish journal of pharmacology _cMar 2013 |
||
| 300 |
_a1215-29 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAction Potentials _xdrug effects |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 |
_aEther-A-Go-Go Potassium Channels _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHEK293 Cells |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypnotics and Sedatives _xpharmacology |
| 650 | 0 | 4 |
_aInduced Pluripotent Stem Cells _xcytology |
| 650 | 0 | 4 |
_aLong QT Syndrome _xchemically induced |
| 650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
| 650 | 0 | 4 |
_aOocytes _xdrug effects |
| 650 | 0 | 4 |
_aPotassium Channel Blockers _xpharmacology |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 | _aXenopus laevis |
| 650 | 0 | 4 | _aZolpidem |
| 700 | 1 | _aFicker, E | |
| 700 | 1 | _aWan, X | |
| 700 | 1 | _aDeschenes, I | |
| 700 | 1 | _aKisselbach, J | |
| 700 | 1 | _aWiedmann, F | |
| 700 | 1 | _aStaudacher, I | |
| 700 | 1 | _aSchmidt, C | |
| 700 | 1 | _aSchweizer, P A | |
| 700 | 1 | _aBecker, R | |
| 700 | 1 | _aKatus, H A | |
| 700 | 1 | _aThomas, D | |
| 773 | 0 |
_tBritish journal of pharmacology _gvol. 168 _gno. 5 _gp. 1215-29 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/bph.12002 _zAvailable from publisher's website |
| 999 |
_c22180804 _d22180804 |
||